Under construction – not a live service
Sign in
Taking peopleNo phase

The Efficacy of Transcutaneous Pulsed Radiofrequency Acupuncture for Knee Osteoarthritis

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 45 and 85 years old?

Source: NCT06702046, who can take part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Shin Kong Wu Ho-Su Memorial Hospital
Trial code
NCT06702046
Record updated
24 April 2026
Original description
Efficacy of transcutaneous acupoint pulsed radiofrequency with rehabilitation for knee osteoarthritis.Read full original descriptionShow less

Efficacy of transcutaneous acupoint pulsed radiofrequency with rehabilitation for knee osteoarthritis.

Inclusion: Age from 45 to 85 year-old with knee pain for more than six months; Fulfill the combined clinical and radiographic criteria of knee OA established by the American College of Rheumatology with a Kellgren and Lawrence score of 2 or greater; Pain score above 3 (range 0-10 on the visual analog scale; higher scores indicate greater pain; Could participate in 4 weeks of treatment and 3 months of follow-up.

Exclusion: Receiving other treatment for knee OA in previous 3 months; Knee OA combined with any infection, inflammation, autoimmune disease, or fracture; History or underlying disease that would affect posture and balance, such as malignancy, dizziness, vertigo, or stroke; History of epilepsy, electronic devices implanted in the body; Active infection at the stimulator contact site; Ever underwent any type of knee operation or internal fixation; Pregnant or planning to become pregnant; Lack of informed consent; Any other reason thought likely to result in inability to complete the trial.

ClinicalTrials.gov NCT06702046